BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16136269)

  • 1. Conversion of Fas-resistant to Fas-sensitive MCF-7 breast cancer cells by the synergistic interaction of interferon-gamma and all-trans retinoic acid.
    Danforth DN; Zhu Y
    Breast Cancer Res Treat; 2005 Nov; 94(1):81-91. PubMed ID: 16136269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-gamma-induced sensitization of colon carcinomas to ZD9331 targets caspases, downstream of Fas, independent of mitochondrial signaling and the inhibitor of apoptosis survivin.
    Geller J; Petak I; Szucs KS; Nagy K; Tillman DM; Houghton JA
    Clin Cancer Res; 2003 Dec; 9(17):6504-15. PubMed ID: 14695155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNF-alpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors' signaling and requires P21(waf1).
    Chopin V; Slomianny C; Hondermarck H; Le Bourhis X
    Exp Cell Res; 2004 Aug; 298(2):560-73. PubMed ID: 15265702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of Apo-1/Fas (CD95)-induced programmed cell death in myeloma cells by interferon-alpha 2.
    Egle A; Villunger A; Kos M; Böck G; Gruber J; Auer B; Greil R
    Eur J Immunol; 1996 Dec; 26(12):3119-26. PubMed ID: 8977313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.
    Menendez JA; Lupu R
    Int J Mol Med; 2005 Jan; 15(1):33-40. PubMed ID: 15583825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    In Vivo; 1999; 13(4):357-73. PubMed ID: 10586378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of mcl-1 by small interfering RNA sensitizes resistant melanoma cells to fas-mediated apoptosis.
    Chetoui N; Sylla K; Gagnon-Houde JV; Alcaide-Loridan C; Charron D; Al-Daccak R; Aoudjit F
    Mol Cancer Res; 2008 Jan; 6(1):42-52. PubMed ID: 18234961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma treatment elevates caspase-8 expression and sensitizes human breast tumor cells to a death receptor-induced mitochondria-operated apoptotic program.
    Ruiz-Ruiz C; Muñoz-Pinedo C; López-Rivas A
    Cancer Res; 2000 Oct; 60(20):5673-80. PubMed ID: 11059759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of Fas-mediated apoptosis in renal cell carcinoma cells by adriamycin.
    Wu XX; Mizutani Y; Kakehi Y; Yoshida O; Ogawa O
    Cancer Res; 2000 Jun; 60(11):2912-8. PubMed ID: 10850437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion of CD95 (Fas) Type II into Type I signaling by sub-lethal doses of cycloheximide.
    Brumatti G; Yon M; Castro FA; Bueno-da-Silva AE; Jacysyn JF; Brunner T; Amarante-Mendes GP
    Exp Cell Res; 2008 Feb; 314(3):554-63. PubMed ID: 18078929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fas expression and function in normal and malignant breast cell lines.
    Keane MM; Ettenberg SA; Lowrey GA; Russell EK; Lipkowitz S
    Cancer Res; 1996 Oct; 56(20):4791-8. PubMed ID: 8841000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon regulatory factor-1-induced apoptosis mediated by a ligand-independent fas-associated death domain pathway in breast cancer cells.
    Stang MT; Armstrong MJ; Watson GA; Sung KY; Liu Y; Ren B; Yim JH
    Oncogene; 2007 Sep; 26(44):6420-30. PubMed ID: 17452973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin E succinate (VES) induces Fas sensitivity in human breast cancer cells: role for Mr 43,000 Fas in VES-triggered apoptosis.
    Yu W; Israel K; Liao QY; Aldaz CM; Sanders BG; Kline K
    Cancer Res; 1999 Feb; 59(4):953-61. PubMed ID: 10029090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptotic behaviour of hepatic and extra-hepatic tumor cell lines differs after Fas stimulation.
    Lamboley C; Bringuier AF; Feldmann G
    Cell Mol Biol (Noisy-le-grand); 2000 Feb; 46(1):13-28. PubMed ID: 10726968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-gamma sensitizes osteosarcoma cells to Fas-induced apoptosis by up-regulating Fas receptors and caspase-8.
    Inaba H; Glibetic M; Buck S; Ravindranath Y; Kaplan J
    Pediatr Blood Cancer; 2004 Dec; 43(7):729-36. PubMed ID: 15390286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
    Sylvester PW; Shah S
    Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-10 protects mouse intestinal epithelial cells from Fas-induced apoptosis via modulating Fas expression and altering caspase-8 and FLIP expression.
    Bharhani MS; Borojevic R; Basak S; Ho E; Zhou P; Croitoru K
    Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G820-9. PubMed ID: 17030898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-alpha and interferon-gamma sensitize human tenon fibroblasts to mitomycin-C.
    Wang XY; Crowston JG; Zoellner H; Healey PR
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3655-61. PubMed ID: 17652735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-gamma and tumor necrosis factor-alpha sensitize primarily resistant human endometrial stromal cells to Fas-mediated apoptosis.
    Fluhr H; Krenzer S; Stein GM; Stork B; Deperschmidt M; Wallwiener D; Wesselborg S; Zygmunt M; Licht P
    J Cell Sci; 2007 Dec; 120(Pt 23):4126-33. PubMed ID: 18003704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
    Mizutani Y; Yoshida O; Bonavida B
    J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.